Steward Partners Investment Advisory, LLC - ELEVATION ONCOLOGY INC ownership

ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 32 filers reported holding ELEVATION ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of ELEVATION ONCOLOGY INC
ValueSharesWeighting
Q4 2022$475
-52.5%
5000.0%0.00%
Q3 2022$1,0000.0%5000.0%0.00%
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,000
-66.7%
5000.0%0.00%
Q4 2021$3,000
-25.0%
5000.0%0.00%
Q3 2021$4,000
-42.9%
5000.0%0.00%
Q2 2021$7,0005000.00%
Other shareholders
ELEVATION ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 2,834,910$38,470,0006.16%
venBio Partners LLC 2,608,167$35,393,0004.18%
Samsara BioCapital, LLC 932,239$12,650,0001.56%
Cormorant Asset Management, LP 1,983,165$25,566,0000.87%
BVF INC/IL 1,590,291$21,580,0000.81%
Boxer Capital, LLC 1,341,530$18,205,0000.64%
Ghost Tree Capital, LLC 100,000$1,357,0000.37%
CAXTON CORP 39,586$537,0000.37%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,999,514$26,456,0000.35%
Vivo Capital, LLC 496,843$6,742,0000.29%
View complete list of ELEVATION ONCOLOGY INC shareholders